Cytokinetics Inc. buy UBS Group AG
Start price
03.04.23
/
50%
€34.60
Target price
03.04.24
€56.02
Performance (%)
87.86%
End price
04.04.24
€65.00
Summary
This prediction ended on 04.04.24 with a price of €65.00. With a performance of 87.86% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cytokinetics Inc. | 5.207% | 5.207% | 148.333% | 118.049% |
| iShares Core DAX® | -0,32 % | -0,46 % | 3,58 % | 53,54 % |
| iShares Nasdaq 100 | -0,38 % | 1,36 % | 35,01 % | 90,07 % |
| iShares Nikkei 225® | -0,91 % | 9,39 % | 62,39 % | 79,90 % |
| iShares S&P 500 | 0,44 % | 0,81 % | 24,78 % | 67,81 % |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at UBS Group AG from $67.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten